These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38972467)

  • 1. Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT.
    Esposito TVF; Rodríguez-Rodríguez C; Blackadar C; Kłodzińska S; Mørck Nielsen H; Saatchi K; Häfeli UO
    Eur J Pharm Biopharm; 2024 Jul; ():114398. PubMed ID: 38972467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018).
    Esposito TVF; Rodríguez-Rodríguez C; Blackadar C; Haney EF; Pletzer D; Hancock REW; Saatchi K; Häfeli UO
    Eur J Pharm Biopharm; 2022 Oct; 179():11-25. PubMed ID: 36028151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002.
    Esposito TVF; Blackadar C; Wu L; Rodríguez-Rodríguez C; Haney EF; Pletzer D; Saatchi K; Hancock REW; Häfeli UO
    Mol Pharm; 2024 Jun; 21(6):2751-2766. PubMed ID: 38693707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
    Jacobsen F; Mittler D; Hirsch T; Gerhards A; Lehnhardt M; Voss B; Steinau HU; Steinstraesser L
    Gene Ther; 2005 Oct; 12(20):1494-502. PubMed ID: 15973442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
    Barlow PG; Svoboda P; Mackellar A; Nash AA; York IA; Pohl J; Davidson DJ; Donis RO
    PLoS One; 2011; 6(10):e25333. PubMed ID: 22031815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular receptor for human host defense peptide LL-37 in monocytes.
    Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
    J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs.
    Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G
    Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.
    Wu WK; Wang G; Coffelt SB; Betancourt AM; Lee CW; Fan D; Wu K; Yu J; Sung JJ; Cho CH
    Int J Cancer; 2010 Oct; 127(8):1741-7. PubMed ID: 20521250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation.
    Suzuki K; Murakami T; Hu Z; Tamura H; Kuwahara-Arai K; Iba T; Nagaoka I
    J Immunol; 2016 Feb; 196(3):1338-47. PubMed ID: 26729811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations.
    Bogdanov IV; Streltsova MA; Kovalenko EI; Sapozhnikov AM; Panteleev PV; Ovchinnikova TV
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration.
    Findlay F; Pohl J; Svoboda P; Shakamuri P; McLean K; Inglis NF; Proudfoot L; Barlow PG
    J Immunol; 2017 Oct; 199(7):2483-2490. PubMed ID: 28814602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
    Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
    Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico assessment of missense point mutations on human cathelicidin LL-37.
    Porto WF; Alencar SA
    J Mol Graph Model; 2023 Jan; 118():108368. PubMed ID: 36335830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
    Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
    J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
    Majewski K; Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E
    Cent Eur J Immunol; 2018; 43(4):453-457. PubMed ID: 30799994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the multifunctional peptide LL-37 in host defense.
    Kai-Larsen Y; Agerberth B
    Front Biosci; 2008 May; 13():3760-7. PubMed ID: 18508470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
    Wang G
    J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.